Synuclein Antibodies

Synucleins are presynaptic proteins involved in synaptic vesicle regulation, and pathological α‑synuclein aggregation defines synucleinopathies such as Parkinson’s disease and dementia with Lewy bodies1,2. β‑synuclein has emerged as a sensitive marker of early synaptic degeneration, with elevated plasma levels indicating early Alzheimer’s‑related synaptic injury3. β‑synuclein increases are detectable even in asymptomatic autosomal‑dominant Alzheimer’s disease, supporting its value for early disease staging4. 

Our various monoclonal antibodies targeting α‑ and β‑synuclein further enable the development of immunoassays for synuclein‑related pathology research.

Contact sales for information
ADx301 - mAb rabbit anti alpha-synuclein

Product number 90572

1 mg
ADx302 - mAb mouse anti alpha-synuclein

Product number 90573

1 mg
ADx305 - mAb mouse anti alpha-synuclein

Product number 90574

1 mg
ADx415 - mAb rabbit anti β-synuclein

Product number 90587

1 mg
ADx416 - mAb recombinant mouse anti β-synuclein

Product number 90588

1 mg

Click here to navigate

  • Contact sales for information
  • Details
  • Insights
  • Product inquiry
  • Related products
  • Webinars

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.